Clinical Studies

Canine Lymphoma Clinical Trial

Nov 11, 2016


Dr. Carrie DeRegis, PhD, DACVIM is participating in a canine lymphoma study being conducted by Iowa State University College of Veterinary Medicine. Pieper Memorial is now enrolling eligible canine participants with peripheral lymph node lymphoma to evaluate the benefit of corticosteroids. To be eligible to participate in the trial, a lymphoma diagnosis has to be confirmed or must be highly suspected and chemotherapy treatment declined. Eligible dogs cannot have received any steroids before enrollment. The study provides FREE palliative prednisone.

For more information or to refer a case please call the liaison office at (860) 894-4949 (available Mon-Fri 8am-5pm).

More About the Study

The Canine LymPhoma Steriod Only (CALYPSO) clinical study is a multi-centered study involving 100 dogs with high grade lymphoma from approximately 15 contributing veterinary schools and specialty practices. The study is focused on determining the response to therapy: how long it lasts, do certain types of lymphoma respond better than others to prednisone, and most importantly how quality of life is improved.

Carrie DeRegis, DVM, PhD, DACVIM

Dr. DeRegis is a board-certified oncologist. She attended Tufts University earning her DVM and graduating as valedictorian of her class in 2002. Following an internship in Small Animal Medicine at Tufts completed in 2003, she went on to earn a PhD in Comparative Biomedical Sciences from Cornell University in 2008. She returned to clinical practice as a Medical Oncology resident at Tufts and completed her training in 2011. Dr. DeRegis continues to be involved in many research studies and publications and Pieper Memorial is happy to support her work with the CALYPSO trial.